Oral coenzyme Q10 supplementation improves clinical symptoms and recovers pathologic alterations in blood mononuclear cells in a fibromyalgia patient.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/22898267
Conclusion of this study
After CoQ10 treatment, the patient reported a significant improvement of clinical symptoms. At the cellular level, CoQ10 treatment restored mitochondrial dysfunction and the mtDNA copy number, decreased oxidative stress, and increased mitochondrial biogenesis. Our results suggest that CoQ10 could be an alternative therapeutic approach for FM.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study